A clinical overview of cholinesterase inhibitors in Alzheimer's disease.

@article{Farlow2002ACO,
  title={A clinical overview of cholinesterase inhibitors in Alzheimer's disease.},
  author={Martin R. Farlow},
  journal={International psychogeriatrics},
  year={2002},
  volume={14 Suppl 1},
  pages={93-126}
}
This review provides an overview of the three most widely used cholinesterase (ChE) inhibitors: donepezil, rivastigmine, and galantamine. Differences in pharmacologic profiles will be discussed, and consideration will be given to how such differences may relate to and influence the clinical efficacy and tolerability of the various agents. In addition to providing cognitive benefits in patients with Alzheimer's disease (AD), growing clinical evidence also suggests that ChE inhibitors can produce… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Current and future treatments for Alzheimer's disease.

Therapeutic advances in neurological disorders • 2013
View 9 Excerpts
Highly Influenced

Disease-modifying treatments for Alzheimer's disease.

Therapeutic advances in neurological disorders • 2011
View 1 Excerpt

Progress in Alzheimer’s disease

Journal of Neurology • 2011
View 1 Excerpt

Similar Papers

Loading similar papers…